• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RANKL/RANK-从骨生理学到乳腺癌。

RANKL/RANK - from bone physiology to breast cancer.

机构信息

IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, 1030 Vienna, Austria.

IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, 1030 Vienna, Austria.

出版信息

Cytokine Growth Factor Rev. 2014 Apr;25(2):205-14. doi: 10.1016/j.cytogfr.2014.01.002. Epub 2014 Jan 10.

DOI:10.1016/j.cytogfr.2014.01.002
PMID:24486161
Abstract

RANK and its ligand RANKL are key molecules in bone metabolism and are critically involved in pathologic bone disorders. Deregulation of the RANK/RANKL system is for example a main reason for the development of postmenopausal osteoporosis, which affects millions of women worldwide. Another essential function of RANK and RANKL is the development of a functional lactating mammary gland during pregnancy. Sex hormones, in particular progesterone, induce RANKL expression resulting in proliferation of mammary epithelial cells. Moreover, RANK and RANKL have been shown to regulate mammary epithelial stem cells. RANK and RANKL were also identified as critical mechanism in the development of hormone-induced breast cancer and metastatic spread to bone. In this review, we will focus on the various RANK/RANKL functions ranging from bone physiology, immune regulation, and initiation of breast cancer.

摘要

RANK 及其配体 RANKL 是骨骼代谢中的关键分子,它们在病理性骨疾病中起着至关重要的作用。RANK/RANKL 系统的失调是导致绝经后骨质疏松症的主要原因之一,这种疾病影响着全球数以百万计的女性。RANK 和 RANKL 的另一个重要功能是在怀孕期间发育出功能性泌乳乳腺。性激素,特别是孕激素,诱导 RANKL 的表达,导致乳腺上皮细胞的增殖。此外,RANK 和 RANKL 已被证明可以调节乳腺上皮干细胞。RANK 和 RANKL 也被确定为激素诱导的乳腺癌发展和转移到骨骼的关键机制。在这篇综述中,我们将重点讨论 RANK/RANKL 的各种功能,包括骨骼生理学、免疫调节和乳腺癌的发生。

相似文献

1
RANKL/RANK - from bone physiology to breast cancer.RANKL/RANK-从骨生理学到乳腺癌。
Cytokine Growth Factor Rev. 2014 Apr;25(2):205-14. doi: 10.1016/j.cytogfr.2014.01.002. Epub 2014 Jan 10.
2
RANKL and RANK in sex hormone-induced breast cancer and breast cancer metastasis.RANKL 和 RANK 在性激素诱导的乳腺癌和乳腺癌转移中的作用。
Trends Endocrinol Metab. 2011 May;22(5):188-94. doi: 10.1016/j.tem.2011.02.007. Epub 2011 Apr 4.
3
Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis.分子途径:RANKL/RANK/OPG 通路在肿瘤发生和转移中的破骨细胞依赖性和破骨细胞独立性作用。
Clin Cancer Res. 2012 Jan 15;18(2):326-35. doi: 10.1158/1078-0432.CCR-10-2507. Epub 2011 Oct 26.
4
RANKL/RANK/OPG system beyond bone remodeling: involvement in breast cancer and clinical perspectives.RANKL/RANK/OPG 系统超越骨重塑:在乳腺癌中的作用及临床意义。
J Exp Clin Cancer Res. 2019 Jan 8;38(1):12. doi: 10.1186/s13046-018-1001-2.
5
Key roles of the OPG-RANK-RANKL system in bone oncology.OPG-RANK-RANKL系统在骨肿瘤学中的关键作用。
Expert Rev Anticancer Ther. 2007 Feb;7(2):221-32. doi: 10.1586/14737140.7.2.221.
6
The osteoprotegerin/RANK/RANKL system: a bone key to vascular disease.骨保护素/RANK/RANKL 系统:血管疾病的关键之骨。
J Endocrinol Invest. 2009;32(4 Suppl):6-9.
7
CLINICAL Review #: the role of receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/osteoprotegerin: clinical implications.临床综述#:核因子κB受体激活剂(RANK)/RANK配体/骨保护素的作用:临床意义
J Clin Endocrinol Metab. 2007 Dec;92(12):4514-21. doi: 10.1210/jc.2007-0646. Epub 2007 Sep 25.
8
The RANKL-RANK Story.RANKL-RANK的故事。
Gerontology. 2015;61(6):534-42. doi: 10.1159/000371845. Epub 2015 Feb 14.
9
[The role of RANK/RANKL/osteoprotegerin (OPG) triad in cancer-induced bone diseases: physiopathology and clinical implications].[RANK/RANKL/骨保护素(OPG)三联体在癌症诱导的骨疾病中的作用:病理生理学及临床意义]
Bull Cancer. 2011 Jul;98(7):837-46. doi: 10.1684/bdc.2011.1398.
10
[The OPG/RANKL/RANK system and bone resorptive disease].[骨保护素/核因子κB受体活化因子配体/核因子κB受体活化因子系统与骨吸收性疾病]
Sheng Wu Gong Cheng Xue Bao. 2003 Nov;19(6):655-60.

引用本文的文献

1
Sea buckthorn and its flavonoids isorhamnetin, quercetin, and kaempferol favorably influence bone and breast tissue health.沙棘及其黄酮类化合物异鼠李素、槲皮素和山奈酚对骨骼和乳腺组织健康有积极影响。
Front Pharmacol. 2024 Oct 9;15:1462823. doi: 10.3389/fphar.2024.1462823. eCollection 2024.
2
's role in RANKL-induced osteoclast differentiation: insights from a bone marrow macrophage model.在 RANKL 诱导的破骨细胞分化中的作用:来自骨髓巨噬细胞模型的见解。
PeerJ. 2024 Oct 9;12:e18222. doi: 10.7717/peerj.18222. eCollection 2024.
3
RANK in cancer-associated fibroblasts: A valuable prognostic determinant for metastasis in early-stage breast cancer patients.
RANK 在癌症相关成纤维细胞中的作用:早期乳腺癌患者转移的有价值的预后判断因素。
Cancer Biomark. 2024;41(2):115-132. doi: 10.3233/CBM-230523.
4
Novel insights linking BRCA1-IRIS role in mammary gland development to formation of aggressive PABCs: the case for longer breastfeeding.将BRCA1-IRIS在乳腺发育中的作用与侵袭性妊娠相关性乳腺癌形成相联系的新见解:延长母乳喂养的理由。
Am J Cancer Res. 2022 Jan 15;12(1):396-426. eCollection 2022.
5
New Generation of Meso and Antiprogestins (SPRMs) into the Osteoporosis Approach.新一代的孕激素拮抗剂(SPRMs)进入骨质疏松症的治疗方法。
Molecules. 2021 Oct 27;26(21):6491. doi: 10.3390/molecules26216491.
6
Update on the Role of Neuropeptide Y and Other Related Factors in Breast Cancer and Osteoporosis.神经肽 Y 及其他相关因子在乳腺癌和骨质疏松症中作用的研究进展。
Front Endocrinol (Lausanne). 2021 Aug 6;12:705499. doi: 10.3389/fendo.2021.705499. eCollection 2021.
7
and Genetic Variations Associated with Osteoporosis and Benign Breast Tumors in Korean Women.与韩国女性骨质疏松症和良性乳腺肿瘤相关的遗传变异。
Genes (Basel). 2021 Mar 6;12(3):378. doi: 10.3390/genes12030378.
8
New Selective Progesterone Receptor Modulators and Their Impact on the RANK/RANKL Complex Activity.新型孕激素受体调节剂及其对 RANK/RANKL 复合物活性的影响。
Molecules. 2020 Mar 13;25(6):1321. doi: 10.3390/molecules25061321.
9
RANKL/RANK/OPG system beyond bone remodeling: involvement in breast cancer and clinical perspectives.RANKL/RANK/OPG 系统超越骨重塑:在乳腺癌中的作用及临床意义。
J Exp Clin Cancer Res. 2019 Jan 8;38(1):12. doi: 10.1186/s13046-018-1001-2.
10
Osteoimmunology of tumor necrosis factor-alpha, IL-6, and RANTES/CCL5: a review of known and poorly understood inflammatory patterns in osteonecrosis.肿瘤坏死因子-α、白细胞介素-6和RANTES/CCL5的骨免疫学:骨坏死中已知和了解不足的炎症模式综述
Clin Cosmet Investig Dent. 2018 Nov 9;10:251-262. doi: 10.2147/CCIDE.S184498. eCollection 2018.